Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D020807:Central Nervous System Parasitic Infections / Q000150:complications / Q000378:metabolism / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D003951:Diagnostic Errors; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006331:Heart Diseases / Q000150:complications / Q000378:metabolism / Q000469:parasitology / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007411:Intestinal Diseases, Parasitic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D007674:Kidney Diseases / Q000150:complications / Q000378:metabolism / Q000469:parasitology / Q000628:therapy; D008174:Lung Diseases, Parasitic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D016778:Malaria, Falciparum / Q000150:complications / Q000378:metabolism / Q000628:therapy; D008297:Male; D010963:Plasmodium falciparum; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000378:metabolism / Q000628:therapy; D011379:Prognosis
D000962:Antimalarials